Skip to Content

Clinical Trial Details

Cancer Related Fatigue in Brain Cancer Patients

A Phase III/Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil) to Reduce Cancer-Related Fatigue in Patients with Globastoma Multiforme.


To determine if the addition of Armodafinil will help reduce patient's reported fatigue associated with chemotherapy and radiation therapy.

Inclusion Criteria:
Must have completed radiation therapy treatments greater than 21 days and less than or equal to 24 months before enrollment. Must meet a certain level of fagitue. Must be willing to complete questionnaires.

Exclusion Criteria:
Currently not taking any medication of ADHD, severe anxiety disorder, schizophrenia or substance abuse.

IRB Protocol Number

Clinical Trial Categories

  • Brain Cancer
Barbara Beauchemin, RN, BSN at 603-224-2556


  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000